全民健康保險藥品給付規定 / 健保碼及健保價 |
See related Cefazolin (CCPC) powd for inj[西華樂林 乾粉注射劑] information |
|
製造商 |
CCPC |
代理/經銷商 |
CCPC |
成份 |
Cefazolin Na |
適應症 |
Infection of the respiratory tract, GUT, skin & soft tissues, biliary tract, bones & joints; septicemia, endocarditis. |
用量 |
Adult Moderate to serious infection: 500 mg to 1 g 6-8 hrly. Mild infection: 250-500 mg 8 hrly. Acute UTI 1 g 12 hrly. Pneumonia 500 mg 12 hrly. Serious sickness 1-1.5 g 6 hrly. Children 20-40 mg/kg in 2 divided doses. |
美國食品藥物管理局之懷孕等級 |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
禁忌 |
Hypersensitivity to cephalosporins. |
注意事項 |
Hypersensitivity to penicillins. Renal impairment. |
不良反應 |
Diarrhea, hypersensitivity reactions, blood disorders, superinfection, headache, dizziness, lassitude.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
交互作用 |
Probenecid, bacteriostatic antibiotics.
View more drug interactions with Cefazolin (CCPC)[西華樂林] |
本商品之市售規格 |
劑型 |
包裝 |
圖片 |
Cefazolin (CCPC) 乾粉注射劑 |
Cefazolin (CCPC) 1 g x 10's |
Cefazolin (CCPC) 1 g x 25's |
Cefazolin (CCPC) 500 mg x 10's |
|
|
Manufacturer: |
CCPC |
Distributor: |
CCPC
|
|
|
|